Structure-activity relationship of antiestrogens. A study using triarylbutenone, benzofuran, and triarylfuran analogs as models for triarylethylenes and triarylpropenones
- 1 August 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 32 (8) , 1700-1707
- https://doi.org/10.1021/jm00128a006
Abstract
In a study of the structure-activity relationship (SAR) of antiestrogens use has been made of certain 1,2,3-triarylbutenones, of 2-arylbenzofurans carrying aryl or aroyl substituents at C3, and 2,3,4-triarylfurans as conformationally constrained models for triarylethylene (TAE) and triarylpropenone (TAP) prototypes. The position-specific contributions of substituents to receptor affinity and to agonist-antagonist profiles were used as aids in characterizing the relative binding orientation of the prototypes. Although most compounds were found to be weak receptor ligands and poorly active in vivo, the following conclusions could be drawn about their SAR: (i) (Z)-TAPs and TAEs interact with the receptor in an analogous manner using the trans-stilbene core, with their agonist-antagonist profiles depending on the nature of other substructures. (ii) Incorporation into the benzofuran framework introduces a stereoelectronic constraint that compromises the normal binding interactions of TAE, as well as TAP, prototypes, resulting in their poor affinities and weak biological activities. (iii) (E)-TAPs can interact with the receptor through their S-cis conformation, but such a binding mode is unlikely to account for their behavior as antagonists.This publication has 9 references indexed in Scilit:
- Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride (LY 156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicityJournal of Medicinal Chemistry, 1984
- Structure-activity relationship of estrogens: A study involving cyclofenyl as the model compoundThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterusMolecular and Cellular Endocrinology, 1982
- Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and miceLife Sciences, 1980
- Synthesis and antiestrogenic activity of [3,4-dihydro-2-(4-methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl]methanone, methanesulfonic acid saltJournal of Medicinal Chemistry, 1979
- Investigations on fungicides. XX. The fungitoxicity of analogues of the phy toalexin 2‐(2‘ ‐methoxy‐4’ ‐hydroxyphenyl)‐6‐methoxybenzofuran(vignafuran)Annals of Applied Biology, 1978
- Mammalian Antifertility Agents. IV. Basic 3,4-Dihydronaphthalenes and 1,2,3,4-Tetrahydro-1-naphtholsJournal of Medicinal Chemistry, 1967
- Mammalian Antifertility Agents. III. 1-Aryl-2-phenyl-1,2,3,4-tetrahydro-1-naphthols, 1-Aryl-2-phenyl-3,4-dihydronaphthalenes, and Their Derivatives1Journal of Medicinal Chemistry, 1966
- A NON-STEROIDAL ESTROGEN ANTAGONIST l-(p-2-DIETHYLAMINOETHOXYPHENYLH-PHENYL-2-p-METHOXYPHENYL ETHANOLEndocrinology, 1958